期刊文献+

5型磷酸二酯酶在不同前列腺组织中表达及相关临床意义 被引量:1

Expression and clinical research of phosphodiesterase 5 in different prostate tissues
原文传递
导出
摘要 目的探讨5型磷酸二酯酶在正常前列腺、良性前列腺增生组织中的表达及其临床意义。方法采用免疫组化技术检测正常前列腺组织及良性前列腺增生组织中的PDE5表达,并探讨PDE5表达与BPH患者的前列腺体积、PSA值、残余尿、年龄I、PSS、Qmax之间的关系。结果免疫组化结果显示:正常前列腺组织PDE5表达极弱,BPH中PDE5高表达。BPH组织中PDE5的表达与前列腺体积I、PSS、残余尿、PSA成正相关,但与年龄、最大尿流率无明显相关性。结论 PDE5在BPH组织中有较强表达,可能对BPH的病理生理过程产生重要作用。 Objective To elucidate the expression of PDE5 in normal prostate and benign prostatic hyperplasia tissues and its clinical significance in patients with BPH.Methods Using immunohistochemical staining methods,we detected PDE5 expression level in the normal prostate and BPH tissues.Results The little PDE5 was detected in the normal prostate tissues while the positive PDE5 was detected in the BPH tissues.The quantization of PDE5 showed no correlation with age of patients and the Qmax,but there was a positive correlation with prostatic volume,IPSS,PVR urine volume and PSA.Conclusion PDE5 is highly expressed in BPH tissues.These results suggest that PDE5 may play functional roles in benign prostatic hyperplasia and may be involved in the pathogenesis of BPH.
出处 《中国误诊学杂志》 CAS 2011年第26期6313-6315,共3页 Chinese Journal of Misdiagnostics
关键词 磷酸二酯水解酶类/代谢 前列腺/代谢 Phosphoric Diester Hydrolases/metabolism Prostate/metabolism
  • 相关文献

参考文献5

  • 1Van der Made F, Bloemers J, Yassem WE, et J. The influence of testosterone combined with a PDE5-inhibitor on cognitive, af- fective, and physiological sexual functioning in women suffering from sexual dysfunction[J]. J Sex Med, 2009, 6(3) :777-790.
  • 2Uckert S, Kuthe A, Jonas U, et al. Characterization and func- tional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate[J].J Urol, 2001, 166(6) :2484-2490.
  • 3Richard B, Matthias O. Age-stratified normal values for prostate volume, PSA, maximum ,urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older[J]. World J Urol, 2011,29(2) : 171-178.
  • 4McVary KT. Lower urinary tract symptoms and sexualdysfunc- tion: epidemiology and pathophysiology[J]. BJU Int, 2006, 97 (2) :23-28.
  • 5McVary KT. Tadalahl relieves lower urinary tract symptoms sec- ondary tO benign prostatic hyperplasia[J]. J Urol, 2007, 177(4) : 1401-1407.

同被引文献6

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部